Accordingly, it can be speculated in our study that lower levels of first-trimester serum hepcidin may imply a state of EPO-stimulated ERFE production, as well as a possible condition of high anemia risk, although all the participating women were below the diagnosis threshold of anemia at enrollment. This evidence concerns the gene EPO and anemia.